CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $251,256 | -23.6% | 11,600 | -9.4% | 0.00% | -42.9% |
Q3 2022 | $329,000 | -36.4% | 12,800 | -45.6% | 0.01% | -61.1% |
Q2 2021 | $517,000 | +128.8% | 23,514 | +25.2% | 0.02% | +28.6% |
Q4 2019 | $226,000 | -61.2% | 18,774 | -62.2% | 0.01% | -85.6% |
Q1 2019 | $583,000 | – | 49,700 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |